A new interdisciplinary study from BYU, opens an angle of neuroimmune research that could potentially lead to better medical ...

Adial Pharmaceuticals has announced the issuance of patent number 12,226,401, which enhances their genetic-based approach for treating alcohol and opioid use disorders. This new patent focuses on ...

Please provide your email address to receive an email when new articles are posted on . At 12 months, 7.1% of patients with AUD and cirrhosis in the naltrexone group vs. 28.6% in the placebo group had ...

Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacologic therapies. While more research is needed, preclinical and ...

The popular weight management and type 2 diabetes medication semaglutide, sold under the brand names Wegovy, Ozempic, and Rybelsus, may reduce alcohol cravings and help people with alcohol use ...